Elysia Capital
Impact investorTurin · 7 people tracked
Investment thesis
Elysia Capital invests in sustainable projects and ideas with the potential to become significant enterprises, backing their evolution and growth. The firm frames its mission around improving the world and increasing the wellbeing of society, aiming to positively influence the lives of as many people as possible. Its outlook emphasizes progress viewed through the lens of nature and the creation of business value that benefits everyone, positioning itself as a bridge toward a new era.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website
What they invest in
from 14 of 25 portfolio companiesConsumer ×4Healthtech ×4Biotech ×3Medical Devices ×3Deep Tech ×2Digital Health ×2Hardware ×2Marketplaces ×2
HQs:Italy×7United States×4Switzerland×1Colombia×1
Investments · 25 tracked
founders shown can be your intro pathAbeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases with high unmet need, including its approved product ZEVASKYN and its lead PSMA-targeted T cell therapy ABO-701 for advanced prostate cancer.
BiotechDigital HealthHealthtechMedical DevicesCleveland, US
Al Hawkins(Chairman and Manager)Timothy Miller(President, Chief Executive Officer and Manager)
Affera develops a medical technology platform for treating cardiac arrhythmias, including atrial fibrillation, using innovative ablation solutions.
HealthtechMedical DevicesNewton, US
Doron Harlev(CEO, Founder)
Co-investorsBain Capital Life Sciences
D-Orbit provides space logistics infrastructure and transportation services including satellite launch deployment, on-orbit servicing, refueling, and end-of-mission disposal using its proprietary ION Satellite Carrier orbital transfer vehicle.
Deep TechLogistics & Supply ChainSpace TechItaly, IT
Luca Rossettini(Founder & CEO)in
Co-investorsBanca Investis — Family OfficeCDP Venture CapitalIceNineIn-Q-TelIndaco Venture PartnersLevante Capital+7 more
EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software.
HealthtechMedical Devices
Giovanni Leo(Co-Founder)Douglas Packer(Co-Founder & Key Advisor)Ugo Amaldi(Co-Founder & Key Advisor)Marina Izzo(Chief Executive Officer & Director)inAdriano Garonna(Chief Technology Officer)inOlivier Coquoz(Head of R&D)
Erbert prepares fresh, ready-to-eat meals without preservatives that heat in two minutes, targeting health-conscious consumers seeking convenient nutritious options in stores, for delivery, or at offices.
ConsumerFoodTechWellness & Fitness
GenomSys develops modular software for storing, processing and sharing genomic data based on the ISO/IEC 23092 MPEG-G standard, serving diagnostic laboratories, hospitals, research centers and biotech companies.
BiotechData & InfrastructureDigital HealthHealthtechSaaSLugano, CH
Antonio Aitoro(Chief Executive Officer)
Jardines Llano Grande is a leisure and hospitality venue offering outdoor dining and relaxation spaces with affiliated restaurants and dining partners.
ConsumerLlano Grande, CO
Co-investors3B Future Health FundCDP Venture CapitalClaris VenturesItalian Angels for Growth
Massimo de Carlo is an art gallery that represents contemporary artists and organizes exhibitions in multiple locations including Hong Kong, London, Milano, and Paris.
Media & EntertainmentMilano, IT
Microchannel Devices manufactures printed circuit heat exchangers (PCHEs) and microchanneled thermal components using chemical etching and diffusion bonding, handling design and production in-house for extreme pressure and temperature conditions.
Advanced ManufacturingEnergyHardware
Co-investorsLIFTT
Visto is a platform that helps brands source custom video content from creators and brand enthusiasts, offering services ranging from open creative challenges to fully produced custom videos and strategic consultation on video distribution.
Creator EconomyMarketing TechMedia & Entertainment
Co-investorsIndaco Venture PartnersLIFTTMACANNovaCapitalPi Campus
Co-investorsNovaCapital
BiotechGreenwhich, US
Wendy DiCicco(Ms. DiCicco is the Secretary and Treasurer of the Issuer.)Arthur Feldman(Director)Magdalene Cook(Executive Officer, Director)Campbell Murray(Director)Edward J. Benz, Jr.(Director)Thomas Needham(Director)
Co-investorsBioAdvance
Sailogy is an online platform for booking sailing and yacht holidays, offering around 22,000 boats across worldwide destinations with options for bareboat or skippered charters.
ConsumerMarketplacesTravel & Hospitality
Co-investorsClub Italia Investimenti 2TiVenture SA
Terabee develops time-of-flight distance sensors, 3D and thermal cameras, and IoT solutions such as people-counting, occupancy, and air-quality devices, serving mobile robotics, industrial process control, smart agriculture, traffic management, and smart buildings applications.
CleantechDeep TechHardwareIoT
Max RuffoBjarne HadlandClaudio Parrinello
Exits · 1
IPOs and acquisitions across the tracked portfolioAbeona TherapeuticsNASDAQ: ABEO
Portfolio news
latest coverage across their companiesD-Orbit · ucapital.com · Jan 23, 2026
Frequently asked questions
- How many investments has Elysia Capital made?
- Elysia Capital has 25 tracked investments.
- What sectors does Elysia Capital focus on?
- Elysia Capital focuses on Biotech, Healthtech, Impact & Social Good, Medical Devices, PropTech, Robotics, Sector Agnostic, Space Tech.
- Where is Elysia Capital located?
- Elysia Capital is headquartered in Turin, IT.
- Who does Elysia Capital co-invest with?
- Elysia Capital most often shares deals with LIFTT, NovaCapital, CDP Venture Capital, among 22 tracked co-investors.
Similar investors
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
The Business Development Bank of Canada (BDC) is a Canadian institution that has supported small and medium-sized businesses for over 80 years, providing financing and advisory services to entrepreneurs across all industries and growth stages.
Flucas Ventures is a solo GP fund led by Ashley Flucas, who simultaneously serves as COO of Summit Ventures while personally investing in 250-275+ startups and deploying over $75M through a syndicate of 2,000+ LPs in less than two years. The fund operates with true stage, sector, and geography agnosticism while democratizing access to top-tier venture deals by inviting diverse, nontraditional LPs to co-invest alongside marquee firms like Sequoia and Andreessen Horowitz.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
MPG Fund is an early-stage venture investor backing technology startups.